Pediatrix Medical Group, Inc. (NYSE:MD) Receives Average Rating of “Hold” from Analysts

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have been assigned an average recommendation of “Hold” from the six brokerages that are currently covering the stock, MarketBeat.com reports. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $16.25.

A number of analysts have recently commented on MD shares. UBS Group upped their target price on Pediatrix Medical Group from $10.50 to $16.50 and gave the stock a “neutral” rating in a research note on Tuesday, November 5th. StockNews.com raised Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. Truist Financial reduced their target price on Pediatrix Medical Group from $16.00 to $15.00 and set a “hold” rating for the company in a report on Monday, January 6th. Jefferies Financial Group upped their price target on Pediatrix Medical Group from $14.00 to $18.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on Pediatrix Medical Group from $9.00 to $15.00 and gave the company a “hold” rating in a research report on Monday, November 4th.

Pediatrix Medical Group Stock Up 1.4 %

Shares of MD opened at $14.24 on Wednesday. Pediatrix Medical Group has a 52 week low of $6.62 and a 52 week high of $16.41. The company has a quick ratio of 1.42, a current ratio of 1.42 and a debt-to-equity ratio of 0.83. The company has a market capitalization of $1.22 billion, a price-to-earnings ratio of -4.65, a PEG ratio of 1.38 and a beta of 1.57. The stock’s 50-day moving average price is $13.80 and its 200-day moving average price is $12.87.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the company. Quest Partners LLC boosted its position in shares of Pediatrix Medical Group by 25.6% during the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock worth $35,000 after buying an additional 622 shares during the period. Everence Capital Management Inc. raised its stake in shares of Pediatrix Medical Group by 7.5% in the fourth quarter. Everence Capital Management Inc. now owns 13,840 shares of the company’s stock valued at $182,000 after acquiring an additional 960 shares in the last quarter. Parkside Financial Bank & Trust raised its stake in shares of Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock valued at $51,000 after acquiring an additional 1,040 shares in the last quarter. Nomura Asset Management Co. Ltd. raised its stake in shares of Pediatrix Medical Group by 95.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company’s stock valued at $33,000 after acquiring an additional 1,220 shares in the last quarter. Finally, Quarry LP raised its stake in shares of Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company’s stock valued at $55,000 after acquiring an additional 1,662 shares in the last quarter. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.